safest glp-1 drugs from the Gray Market Research Reveals Potential Risks of
Description
"The Effect of Liraglutide, a Long-Acting Glucagon-Like Peptide 1 Derivative, on Glycemic Control, Body Composition, and 24-h Energy Expenditure in Patients With Type 2 Diabetes" (PDF)
Please click the button below to indicate that you are
Zheng T, Baskota A, Gao Y, Chen T, Tian H, Yang F
The findings also could be influenced by the small number of people in the study, he adds
One multidisciplinary effort was presented at the International Food Addiction Consensus Conference in 2024, which will be followed by the next conference in Sep 2025 in London
PubMedPMC 86
